2,3-Dimethoxypyridine

We are 2,3-Dimethoxypyridine CAS:52605-97-7 manufacturer and supplier in China, Pls send inquiry of to info@nbinno.com of visit www.nbinno.com our official website should you have any interests

Chemical Name:2,3-Dimethoxypyridine
CAS.NO:52605-97-7
Synonyms:2,3-Dimethoxypyridine
2,3-dimethoxy-pyridine
 
Physical and Chemical Properties:
Density 1.1±0.1 g/cm3
Boiling Point 179.8±20.0 °C at 760 mmHg
Molecular Formula C7H9NO2
Molecular Weight 139.152
Flash Point 63.6±12.0 °C
 
Specification:
Appearance:Yellow Liquid
Assay:≥98.0%
 
Packing:200 kg/drum, can also be packaged according to customer requirements
Storage:Store in a cool, ventilated place
Application:Organic synthesis intermediate

2,3-Dimethoxypyridine


Related News: Beta Bionics is committed to obtaining regulatory approval and commercializing all three iLet configurations.6-Chlorooxindole The bulk-buy program, which currently covers 25 types of medicines, allows no more than three successful bidders access to China’s public hospitals, where most Chinese people buy their drugs.25360-10-5 The bulk-buy program, which currently covers 25 types of medicines, allows no more than three successful bidders access to China’s public hospitals, where most Chinese people buy their drugs.4 – [(5-bromo-2-clorofenil) metil] fenol CAS:864070-18-8 The Company’s immuno-regulatory product candidates include ProTmune, a pharmacologically modulated, donor cell graft that is currently being evaluated in a Phase 2 clinical trial for the prevention of graft-versus-host disease, and a myeloid-derived suppressor cell immunotherapy for promoting immune tolerance in patients with immune disorders. Fate Therapeutics is headquartered in San Diego, CA.The Company’s immuno-regulatory product candidates include ProTmune, a pharmacologically modulated, donor cell graft that is currently being evaluated in a Phase 2 clinical trial for the prevention of graft-versus-host disease, and a myeloid-derived suppressor cell immunotherapy for promoting immune tolerance in patients with immune disorders. Fate Therapeutics is headquartered in San Diego, CA.

Related Products
Product Name
6-amino-4-chloro-7-ethoxyquinoline-3-carbonitrile View Details
3,4-Dimethyl-1,2-cyclopentanedione View Details
(alphaR)-alpha-[[[2-(4-Aminophenyl)ethyl]amino]methyl]benzenemethanol hydrochloride View Details
4-Chlorobutyl Acetate manufacturer N-(4-Fluoro-2-methoxy-5-nitrophenyl)-4-(1-methyl-1H-indol-3-yl)-2-pyrimidinamine manufacturer 2′,3′-O-Isopropylideneadenosine manufacturer 4,4-Difluoropiperidine hydrochloride manufacturer 2-Fluoro-6-methylpyridine manufacturer